These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30019835)

  • 21. Frailty as a predictive factor for survival after liver transplantation, especially for patients with MELD≤15-a prospective study.
    Klein CG; Malamutmann E; Latuske J; Tagay S; Dörri N; Teufel M; Paul A; Oezcelik A
    Langenbecks Arch Surg; 2021 Sep; 406(6):1963-1969. PubMed ID: 33847783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in frailty are associated with waitlist mortality in patients with cirrhosis.
    Lai JC; Dodge JL; Kappus MR; Dunn MA; Volk ML; Duarte-Rojo A; Ganger DR; Rahimi RS; McCulloch CE; Haugen CE; McAdams-DeMarco M; Ladner DP; Segev DL; Verna EC;
    J Hepatol; 2020 Sep; 73(3):575-581. PubMed ID: 32240717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective analysis of factors associated with decreased physical activity in patients with cirrhosis undergoing transplant evaluation.
    Dela Cruz AC; Vilchez V; Kim S; Barnes B; Ravinuthala A; Zanni A; Galuppo R; Sourianarayanane A; Patel T; Maynard E; Shah MB; Daily MF; Uhl T; Esser K; Gedaly R
    Clin Transplant; 2015 Nov; 29(11):958-64. PubMed ID: 26263921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic assessment in patients with hepatic encephalopathy.
    García-Martínez R; Simón-Talero M; Córdoba J
    Dis Markers; 2011; 31(3):171-9. PubMed ID: 22045403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders?
    Pflugrad H; Bronzlik P; Raab P; Tryc AB; Goldbecker A; Barg-Hock H; Strassburg CP; Ding XQ; Lanfermann H; Weissenborn K
    Liver Int; 2015 Jul; 35(7):1816-23. PubMed ID: 25546380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frailty and reduced gait speed are independently related to mortality of cirrhotic patients in long-term follow-up.
    Soto R; Díaz LA; Rivas V; Fuentes-López E; Zalaquett M; Bruera MJ; González C; Mezzano G; Benítez C
    Ann Hepatol; 2021; 25():100327. PubMed ID: 33596465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis.
    Sinclair M; Chapman B; Hoermann R; Angus PW; Testro A; Scodellaro T; Gow PJ
    Liver Transpl; 2019 Oct; 25(10):1480-1487. PubMed ID: 31282126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis.
    Orman ES; Roberts A; Ghabril M; Nephew L; Desai AP; Patidar K; Chalasani N
    JAMA Netw Open; 2019 Jun; 2(6):e196412. PubMed ID: 31251379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Range and Reproducibility of the Liver Frailty Index.
    Wang CW; Lebsack A; Chau S; Lai JC
    Liver Transpl; 2019 Jun; 25(6):841-847. PubMed ID: 30884128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.
    Schwarzer R; Reiberger T; Mandorfer M; Kivaranovic D; Hametner S; Hametner S; Paternostro R; Scheiner B; Schneeweiss-Friedl J; Trauner M; Schoefl R; Maieron A
    J Gastroenterol; 2020 May; 55(5):533-542. PubMed ID: 31832759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
    Cordoba J; Ventura-Cots M; Simón-Talero M; Amorós À; Pavesi M; Vilstrup H; Angeli P; Domenicali M; Ginés P; Bernardi M; Arroyo V;
    J Hepatol; 2014 Feb; 60(2):275-81. PubMed ID: 24128414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease.
    Stewart CA; Malinchoc M; Kim WR; Kamath PS
    Liver Transpl; 2007 Oct; 13(10):1366-71. PubMed ID: 17520742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
    Patidar KR; Thacker LR; Wade JB; Sterling RK; Sanyal AJ; Siddiqui MS; Matherly SC; Stravitz RT; Puri P; Luketic VA; Fuchs M; White MB; Noble NA; Unser AB; Gilles H; Heuman DM; Bajaj JS
    Am J Gastroenterol; 2014 Nov; 109(11):1757-63. PubMed ID: 25178701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The feasibility of assessing frailty and sarcopenia in hospitalised older people: a comparison of commonly used tools.
    Ibrahim K; Howson FFA; Culliford DJ; Sayer AA; Roberts HC
    BMC Geriatr; 2019 Feb; 19(1):42. PubMed ID: 30770722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites.
    Yoo HY; Edwin D; Thuluvath PJ
    Am J Gastroenterol; 2003 Jun; 98(6):1395-9. PubMed ID: 12818287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study.
    Lai JC; Ganger DR; Volk ML; Dodge JL; Dunn MA; Duarte-Rojo A; Kappus MR; Rahimi RS; Ladner DP; Boyarsky B; McAdams-DeMarco M; Segev DL; McCulloch CE; Verna EC
    JAMA Surg; 2021 Mar; 156(3):256-262. PubMed ID: 33377947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study.
    Jepsen P; Christensen J; Weissenborn K; Watson H; Vilstrup H
    BMC Gastroenterol; 2016 Jul; 16(1):77. PubMed ID: 27457247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation.
    Wedd J; Bambha KM; Stotts M; Laskey H; Colmenero J; Gralla J; Biggins SW
    Liver Transpl; 2014 Oct; 20(10):1193-201. PubMed ID: 24916539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frailty as Tested by Gait Speed Is a Risk Factor for Liver Transplant Respiratory Complications.
    Salim TI; Nestlerode LC; Lucatorto EL; Wasserman TL; Din HA; Landsittel DP; Tevar AD; Johnson JT; Duarte-Rojo A; Dunn MA
    Am J Gastroenterol; 2020 Jun; 115(6):859-866. PubMed ID: 32235146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.